Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

Abstract Background Frunevetmab, a felinized antinerve growth factor monoclonal antibody, effectively decreases osteoarthritis (OA) pain in cats. Objective To evaluate the efficacy of frunevetmab given at monthly intervals in a randomized, placebo‐controlled, parallel‐group, double‐blind superiority...

Full description

Bibliographic Details

Published in:	Journal of Veterinary Internal Medicine
Main Authors:	Margaret E. Gruen, Jamie A. E. Myers, Jezaniah‐Kira S. Tena, Csilla Becskei, Dawn M. Cleaver, B. Duncan X. Lascelles
Format:	Article
Language:	English
Published:	Oxford University Press 2021-11-01
Subjects:	arthritis client specific outcome measures CSOM degenerative joint disease feline feline musculoskeletal pain index
Online Access:	https://doi.org/10.1111/jvim.16291